(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 21.50%128.15B | 33.39%79.52B | 59.83%40.07B | 166.74%141.1B | 150.61%105.48B | 148.88%59.61B | 94.06%25.07B | -29.03%52.9B | -26.75%42.09B | -36.40%23.95B |
Operating income | 21.50%128.15B | 33.39%79.52B | 59.83%40.07B | 166.74%141.1B | 150.61%105.48B | 148.88%59.61B | 94.06%25.07B | -29.03%52.9B | -26.75%42.09B | -36.40%23.95B |
Operating expenses | -22.99%-119.75B | -47.15%-38.73B | -58.54%-97.36B | -33.68%-26.32B | 2.75%-61.41B | |||||
Gross profit | 3.52%8.4B | 206.81%1.34B | 142.01%8.12B | 81.51%-1.25B | -239.44%-19.32B | |||||
Selling expenses | -24.92%-4.99B | -47.56%-2.28B | -55.41%-1.74B | -108.76%-3.42B | -47.31%-4B | -69.74%-1.54B | -6.85%-1.12B | 36.35%-1.64B | 18.20%-2.71B | 20.31%-908.62M |
Administrative expenses | -5.15%-3.92B | -10.50%-780.31M | -16.15%-1.29B | -35.71%-1.68B | -15.41%-3.73B | -39.03%-706.17M | -4.16%-1.11B | 1.80%-1.24B | 0.39%-3.23B | -8.19%-507.94M |
Research and development expenses | -37.23%-293.45M | ---- | -22.43%-85.31M | ---- | -69.45%-213.84M | ---- | -82.88%-69.68M | ---- | -35.97%-126.2M | ---- |
Profit from asset sales | 38.94%958.22M | ---- | -110.61%-2.69M | ---- | 21,814.86%689.66M | ---- | 2,025.82%25.36M | ---- | -112.31%-3.18M | ---- |
Employee expense | ---- | -24.71%-16.95B | ---- | -15.64%-29.3B | ---- | -18.79%-13.59B | ---- | -4.57%-25.34B | ---- | -1.26%-11.44B |
Depreciation and amortization | ---- | -10.39%-14.03B | ---- | -27.68%-27.11B | ---- | -21.48%-12.7B | ---- | -1.43%-21.23B | ---- | -1.23%-10.46B |
Revaluation surplus | 112.38%88K | ---- | 112.55%34K | ---- | -13.94%-711K | ---- | 58.75%-271K | ---- | ---624K | ---- |
-Changes in the fair value of other assets | 112.38%88K | ---- | 112.55%34K | ---- | -13.94%-711K | ---- | 58.75%-271K | ---- | ---624K | ---- |
Impairment and provision | 93.05%-8.61M | 86.04%-14.33M | -126.10%-10M | -406.39%-211.67M | -56,672.02%-123.76M | -745.47%-102.67M | -189.37%-4.42M | 67.89%-41.8M | -100.23%-218K | 270.94%15.91M |
-Other impairment is provision | 93.05%-8.61M | 86.04%-14.33M | -126.10%-10M | -406.39%-211.67M | -56,672.02%-123.76M | -745.47%-102.67M | -189.37%-4.42M | -125.62%-41.8M | -100.23%-218K | 270.94%15.91M |
Special items of operating profit | -0.94%5.4B | -46.11%-46.55B | 18.20%1.61B | -96.88%-76.48B | 260.58%5.45B | -80.80%-31.86B | 696.90%1.37B | 8.08%-38.85B | 13.89%1.51B | 13.84%-17.62B |
Operating profit | -10.91%5.29B | -20.46%-1.08B | 89.18%-241.86M | 108.15%2.89B | 124.74%5.93B | 94.71%-898.2M | 75.70%-2.24B | -110.20%-35.44B | -116.33%-23.98B | -180.88%-16.97B |
Financing income | ---- | -15.70%245.62M | ---- | 164.52%605M | ---- | 215.49%291.38M | ---- | 104.10%228.72M | ---- | 124.09%92.36M |
Financing cost | 29.97%-4.46B | 7.82%-3.27B | -60.95%-1.7B | -7.27%-6.94B | 32.05%-6.36B | -12.76%-3.54B | 15.34%-1.06B | -17.79%-6.47B | -160.63%-9.36B | -18.17%-3.14B |
Share of profits of associates | ---- | -14.28%1.08B | ---- | 635.05%2.55B | ---- | 221.53%1.27B | ---- | 56.15%-477.41M | ---- | 26.61%-1.04B |
Share of profit from joint venture company | ---- | 2.86%91.36M | ---- | -25.82%279.57M | ---- | -60.85%88.82M | ---- | 38.07%376.87M | ---- | 105.74%226.89M |
Special items of earning before tax | -81.81%249.45M | 76.97%-360.42M | 63.87%20.51M | 74.68%-1.04B | 8,257.19%1.37B | 30.11%-1.57B | 35.04%12.51M | -430.95%-4.09B | -150.85%-16.81M | -497.48%-2.24B |
Earning before tax | 14.67%1.08B | 24.63%-3.29B | 41.32%-1.93B | 96.40%-1.65B | 102.82%941.12M | 81.11%-4.36B | 68.56%-3.28B | -110.20%-45.88B | -127.80%-33.36B | -145.36%-23.08B |
Tax | -226.11%-309.88M | -179.86%-252.54M | -962.19%-75.74M | -87.41%88.53M | -74.14%245.72M | -63.30%316.22M | -98.46%8.79M | -76.59%702.98M | -66.65%950.07M | -50.32%861.65M |
After-tax profit from continuing operations | -35.18%769.27M | 12.50%-3.54B | 38.85%-2B | 96.54%-1.56B | 103.66%1.19B | 81.80%-4.04B | 66.84%-3.27B | -140.00%-45.17B | -174.76%-32.41B | -189.60%-22.21B |
Earning after tax | -35.18%769.27M | 12.50%-3.54B | 38.85%-2B | 96.54%-1.56B | 103.66%1.19B | 81.80%-4.04B | 66.84%-3.27B | -140.00%-45.17B | -174.76%-32.41B | -189.60%-22.21B |
Minority profit | -249.84%-592.48M | -27.22%-759.66M | 5.70%-327.44M | 92.03%-522.84M | 109.18%395.42M | 78.50%-597.14M | 64.27%-347.24M | -199.78%-6.56B | -192.19%-4.31B | -212.32%-2.78B |
Profit attributable to shareholders | 72.06%1.36B | 19.38%-2.78B | 42.78%-1.67B | 97.31%-1.04B | 102.82%791.42M | 82.27%-3.45B | 67.12%-2.93B | -132.14%-38.62B | -172.27%-28.1B | -186.62%-19.44B |
Basic earnings per share | 80.00%0.09 | 21.08%-0.1767 | 42.11%-0.11 | 97.60%-0.0674 | 102.44%0.05 | 84.18%-0.2239 | 70.77%-0.19 | -132.13%-2.8116 | -173.33%-2.05 | -186.63%-1.4151 |
Diluted earnings per share | 80.00%0.09 | 21.08%-0.1767 | 97.60%-0.0674 | 0.05 | 84.18%-0.2239 | -132.13%-2.8116 | -186.63%-1.4151 | |||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data